LEDERMAN SETH 4

What Happened

• Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (TNXP), purchased 5,000 shares in open-market transactions on June 9, 2026. The reported weighted-average purchase price was $11.79 per share, for a total reported cost of $58,950. This was a purchase (insider buy), which some investors view as a potentially bullish signal.

Key Details

• Transaction date: 2026-06-09
• Transaction type/code: Open market purchase (P)
• Shares acquired: 5,000
• Weighted-average price: $11.79 per share (range noted $11.735 to $11.883 per share)
• Total value: $58,950
• Shares owned after transaction: Not specified in the provided filing excerpt
• Footnotes:
  • F1: The $11.79 figure is a weighted average; the Reporting Person will provide exact share counts at each price on request to the SEC, issuer, or security holder.
  • F2: The Reporting Person may be deemed a control person of the entity referenced in the filing.
• Timeliness: Filing date and report period are 2026-06-09; filing appears timely (no late filing indicated).

Context

• This was a straightforward open-market purchase (code P). Purchases by executives can be interpreted by some investors as a sign of confidence, but they do not guarantee future performance. No option exercises, awards, gifts, or tax-withholding transactions were reported in this filing.